newsfilter
← Latest News
GlobeNewswire·

AVITA Medical to Announce Third Quarter 2025 Financial Results

  • AVITA Medical will report third quarter 2025 financial results after the U.S. market close on Thursday, November 6, 2025.
  • The company will host a conference call & webcast at 1:30 p.m. Pacific Time on Friday, November 7, 2025 (8:30 a.m. Australian Eastern Daylight Time).
  • The live webcast will be available via the Events & Presentations section of ir.avitamedical.com, with a replay posted shortly after the event.
  • Telephone participants must register in advance using the provided link to receive dial-in details & a personal PIN.
  • AVITA Medical's RECELL System is FDA-approved for thermal burn & trauma wounds & utilizes patient skin to create Spray-On Skin™ Cells.
  • In the U.S., AVITA holds exclusive rights to manufacture & distribute PermeaDerm & market, sell, & distribute Cohealyx.
  • International regulatory clearances for the RECELL System include Europe, Australia, & Japan, excluding the RECELL GO variant.